Yahoo Web Search

Search results

1. • Plaque psoriasis plagues Marietta man for over 30 years until new treatment

     Fox local via AOL· 6 hours ago

     Greg Morrison of Marietta has been struggling with plaque psoriasis and psoriatic arthritis for more than 30 years. Four months ago, ...

2. • 

     Refractory Psoriasis Can Be Overcome, Experts Say

     MedPage Today· 4 days ago

     Treatment failure and relapse are common in diseases of chronic inflammation, and psoriasis is no exception. It is unclear if failure rates are higher in...

3. • 

     What Is Nail Pitting?

     Health via Yahoo News· 2 weeks ago

     Pitting occurs because something disrupts the normal nail formation. It's often related to autoimmune conditions like psoriatic arthritis (PsA). Some...

4. • Worldwide Prevalence of PsA: Meta-Analysis Sheds Light

     Medscape· 4 days ago

     PsA is more prevalent in Europe and North America than in Asia and South America, according to a meta-analysis that assessed the worldwide PsA prevalence.

5. • VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of...

     Morningstar· 15 hours ago

     Do you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ: VTYX)? Did you purchase your shares pursuant and/or traceable to the Company’s October 21, 2021 IPO, or between October 21 ...

6. • FDA Accepts Application for a New HS Treatment

     Medscape· 2 weeks ago

     Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

7. • 509 Bandwidth Limit Exceeded

     TheStreet.com· 2 days ago

     ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTYX PR Newswire NEW YORK, April 14, 2024 NEW YORK, April 14, 2024 /PRNewswire/ -

8. • 

     MoonLake and Komodo sign 3-year deal for health analytics tech

     FierceBiotech· 5 days ago

     MoonLake’s pipeline is directed primarily at inflammatory conditions. The biotech's new partnership...

9. • 

     Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease

     KFDX Wichita Falls· 5 days ago

     IFPA is delighted to announce the 7th IFPA Conference set to take place from June 27th to June 29th,...

10. • INVESTOR INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx...

      KLAS Las Vegas· 3 days ago

      Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and reminds investors ...